Inventor
HOON DAVE S B
US19 patents
⚠️ This page may combine multiple inventors who share the name “HOON DAVE S B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
WAYNE JOHN CANCER INST
11 patentsUS6472375B1Oct 29, 2002
DNA vaccine and methods for its use
WAYNE JOHN CANCER INST178 citations98
US6432925B1Aug 13, 2002
RNA cancer vaccine and methods for its use
WAYNE JOHN CANCER INST54 citations96
US6465177B1Oct 15, 2002
Detection of loss of heterozygosity in tumor and serum of melanoma patients
WAYNE JOHN CANCER INST70 citations95
US7718364B2May 18, 2010
DNA markers for management of cancer
WAYNE JOHN CANCER INST8 citations83
US7910295B2Mar 22, 2011
Detection of micro metastasis of melanoma and breast cancer in paraffin-embedded tumor draining lymph nodes by multimarker quantitative RT-PCR
WAYNE JOHN CANCER INST17 citations79
US8039218B2Oct 18, 2011
Detection of cancer cells in body fluids
WAYNE JOHN CANCER INST2 citations62
US7851161B2Dec 14, 2010
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer
WAYNE JOHN CANCER INST2 citations56
US7897336B2Mar 1, 2011
Molecular lymphatic mapping of sentinel lymph nodes
WAYNE JOHN CANCER INST0 citations51
US7829283B2Nov 9, 2010
Methylation of estrogen receptor alpha and uses thereof
WAYNE JOHN CANCER INST0 citations51
US7888033B2Feb 15, 2011
Use of ID4 for diagnosis and treatment of cancer
WAYNE JOHN CANCER INST0 citations45
US7943319B2May 17, 2011
Utility of RET mutant in diagnosis and treatment of melanoma
WAYNE JOHN CANCER INST0 citations39
HOON DAVE S B
4 patentsUS9410206B2Aug 9, 2016
Long noncoding RNA (lncRNA) as a biomarker and therapeutic marker in cancer
HOON DAVE S B30 citations87
US9567640B2Feb 14, 2017
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer
HOON DAVE S B13 citations82
US9556491B2Jan 31, 2017
Utility of B-RAF DNA mutation in diagnosis and treatment of cancer
HOON DAVE S B14 citations82
US8288099B2Oct 16, 2012
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer
HOON DAVE S B0 citations45